Sep 16, 2020 6:25am EDT Lexaria Bioscience Supports Corporate Growth Initiatives by its Licensee, Cannadips CBD by the Boldt Runners Corporation
Jul 28, 2020 6:30am EDT Lexaria BioScience Receives Ethics Board Approval to Conduct Exploratory Clinical Study using Cannabidiol for Blood Pressure Reduction
Jul 21, 2020 6:15am EDT Lexaria BioScience Files Application with Senior U.S. Stock Exchange for Uplisting
Jun 29, 2020 4:15pm EDT Lexaria Bioscience Engages Investor Relations and Capital Markets Advisory Firm for its Shareholder Communications Program
Jun 18, 2020 6:30am EDT Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License
Jun 01, 2020 4:35pm EDT Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations Services
